Email updates

Keep up to date with the latest news and content from BMC Public Health and BioMed Central.

Open Access Research article

High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population

Timo E Saaristo1*, Noël C Barengo23, Eeva Korpi-Hyövälti4, Heikki Oksa5, Hannu Puolijoki4, Juha T Saltevo6, Mauno Vanhala7, Jouko Sundvall8, Liisa Saarikoski8, Markku Peltonen8 and Jaakko Tuomilehto2

Author Affiliations

1 Finnish Diabetes Association, Kirjoniementie 15, FIN-33680, Tampere, Finland

2 Department of Public Health, University of Helsinki, Finland

3 Unit of Epidemiology and Clinical Research, University Hospital la Paz, Madrid, Spain

4 Department of Internal Medicine, South Ostrobothnia Central Hospital, Finland

5 Tampere University Hospital, Tampere, Finland

6 Central Hospital of Middle Finland, Jyväskylä, Finland

7 Laukaa Health Center, Finland

8 National Public Health Institute, Helsinki, Finland

For all author emails, please log on.

BMC Public Health 2008, 8:423  doi:10.1186/1471-2458-8-423

Published: 29 December 2008

Abstract

Background

There is a worldwide increase in the prevalence of obesity and disturbances in glucose metabolism. The aim of this study was to assess the current prevalence of obesity, central obesity and abnormal glucose tolerance in Finnish population, and to investigate the associations between body mass index (BMI), waist circumference and abnormal glucose tolerance.

Methods

A cross-sectional population-based survey was conducted in Finland during October 2004 and January 2005. A total of 4500 randomly selected individuals aged 45–74 years were invited to a health examination that included an oral glucose tolerance test. The participation rate was 62% in men and 67% in women.

Results

The prevalence of obesity was 23.5% (95% Confidence Interval (CI) 21.1–25.9) in men, and 28.0% (95% CI 25.5–30.5) in women. The overall prevalence of abnormal glucose tolerance (including type 2 diabetes, impaired glucose tolerance, or impaired fasting glucose) was 42.0% (95% CI 39.2–44.8) in men and 33.4% (95% CI 30.9–36.0) in women. The prevalence of previously unknown, screen-detected type 2 diabetes was 9.3% (95% CI 7.7–11.0) in men and 7.3% (95% CI 5.9–8.7) in women. Central obesity was associated with abnormal glucose tolerance within each of the three BMI categories normal (< 25 kg/m2), overweight (25–29 kg/m2), and obese (≥ 30 kg/m2).

Conclusion

In a population-based random sample of Finnish population, prevalences of obesity, central obesity and abnormal glucose tolerance were found to be high. A remarkably high number of previously undetected cases of type 2 diabetes was detected. Waist circumference is a predictor of abnormal glucose tolerance in all categories of obesity.